PMCPA Case
| Case number | AUTH/3288/12/19 |
| Complainant | Anonymous, non-contactable individual who stated that he/she worked in the NHS |
| Company | Biogen |
| Product | Tysabri |
| Allegation | MSL promoted Tysabri and its benefits to an MS patient at a social event, leading to a request to switch therapy |
| Setting | Wedding/social event (May 2019; described as summer 2019) |
| Complaint received | 13 December 2019 |
| Case completed | 16 September 2020 |
| Applicable Code year | 2019 |
| Appeal | No appeal |
| Decision | No breach |
| Clauses considered | 2; 9.1; 12.1; 15.2; 26.1; 26.2 |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.